Allergy Therapeutics plc

Allergy Therapeutics plcverified

AGYTF

Price:

$0.11

Market Cap:

$496.27M

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-02-03

Stock Exchange

OTC

Ticker

AGYTF

The Current Ratio as of December 2025 (TTM) for Allergy Therapeutics plc (AGYTF) is 1.60

According to Allergy Therapeutics plc’s latest financial reports and current stock price. The company's current Current Ratio is 1.60. This represents a change of -0.75% compared to the average of 1.61 of the last 4 quarters.

Allergy Therapeutics plc (AGYTF) Historical Current Ratio (quarterly & annually)

How has AGYTF Current Ratio performed in the past?

The mean historical Current Ratio of Allergy Therapeutics plc over the last ten years is 2.71. The current 1.60 Current Ratio has changed 5.79% with respect to the historical average. Over the past ten years (40 quarters), AGYTF's Current Ratio was at its highest in in the June 2006 quarter at 6.29. The Current Ratio was at its lowest in in the June 2009 quarter at 0.43.

Quarterly (TTM)
Annual

Average

2.71

Median

2.72

Minimum

1.63

Maximum

4.55

Allergy Therapeutics plc (AGYTF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Allergy Therapeutics plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.45%

Maximum Annual Current Ratio = 4.55

Minimum Annual Increase = -34.03%

Minimum Annual Current Ratio = 1.63

Quarterly (TTM)
Annual
YearCurrent RatioChange
20241.63-9.76%
20231.81-23.10%
20222.35-26.01%
20213.174.85%
20203.039.45%
20192.7730.83%
20182.11-20.88%
20172.67-11.06%
20163.00-34.03%
20154.55107.45%

Allergy Therapeutics plc (AGYTF) Average Current Ratio

How has AGYTF Current Ratio performed in the past?

The current Current Ratio of Allergy Therapeutics plc (AGYTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.93

5-year avg

2.40

10-year avg

2.71

Allergy Therapeutics plc (AGYTF) Current Ratio vs. Peers

How is AGYTF’s Current Ratio compared to its peers?

Allergy Therapeutics plc’s Current Ratio is less than Verano Holdings Corp. (2.69), less than Glass House Brands Inc. (1.99), greater than ManifestSeven Holdings Corporation (0.13), less than Cresco Labs Inc. (3.10), less than Boiron S.A. (2.39), greater than JCR Pharmaceuticals Co., Ltd. (1.11), less than MedinCell S.A. (2.70), less than YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1.77), less than Hua Medicine (Shanghai) Ltd. (7.79), greater than Lattice Biologics Ltd. (0.12),

Build a custom stock screener for Allergy Therapeutics plc (AGYTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allergy Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Allergy Therapeutics plc (AGYTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Allergy Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Allergy Therapeutics plc's Current Ratio?

How is the Current Ratio calculated for Allergy Therapeutics plc (AGYTF)?

What is the highest Current Ratio for Allergy Therapeutics plc (AGYTF)?

What is the 3-year average Current Ratio for Allergy Therapeutics plc (AGYTF)?

What is the 5-year average Current Ratio for Allergy Therapeutics plc (AGYTF)?

How does the current Current Ratio for Allergy Therapeutics plc (AGYTF) compare to its historical average?